Dyadic International (DYAI) Gross Profit (2018 - 2025)
Dyadic International (DYAI) posted Gross Profit of $267092.0 for Q1 2025, down 42.51% sequentially from $464557.0 in Q4 2024, and down 20.18% YoY from $334617.0 in Q1 2024.
Dyadic International (DYAI) Gross Profit (2018 - 2025) Analysis & Trends
Dyadic International has reported Gross Profit for 8 years, with the latest figure at $267092.0 in Q1 2025.
- Quarterly Gross Profit fell 20.18% year-over-year to $267092.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $2.4 million (up 136.2% YoY) and the FY2024 annual result came in at $2.3 million, up 149.28% from the prior year.
- Gross Profit declined to $267092.0 in Q1 2025 per DYAI's latest filing, from $464557.0 in the prior quarter.
- Over five years, Gross Profit peaked at $69.8 million in Q1 2021 and troughed at -$18338.0 in Q4 2021.
- A 5-year average of $4.4 million and a median of $267092.0 in 2025 frame the typical range for Gross Profit.
- The widest YoY moves for Gross Profit: up 187471.93% in 2021, down 120.3% in 2021.
- Over 5 years, Gross Profit stood at -$18338.0 in 2021, then jumped by 313.95% to $39235.0 in 2022, then jumped by 757.44% to $336417.0 in 2023, then jumped by 38.09% to $464557.0 in 2024, then plunged by 42.51% to $267092.0 in 2025.
- According to Business Quant data, Gross Profit over the past three periods registered $267092.0, $464557.0, and $1.6 million for Q1 2025, Q4 2024, and Q3 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 267,092.00 |
| Mar 31, 2025 | 267,092.00 |
| Dec 31, 2024 | 464,557.00 |
| Dec 31, 2024 | 464,557.00 |
| Sep 30, 2024 | 1.56 Mn |
| Sep 30, 2024 | 1.56 Mn |
| Jun 30, 2024 | 83,940.00 |
| Jun 30, 2024 | 83,940.00 |
| Mar 31, 2024 | 334,617.00 |
| Mar 31, 2024 | 334,617.00 |
| Dec 31, 2023 | 336,417.00 |
| Dec 31, 2023 | 336,417.00 |
| Sep 30, 2023 | 291,191.00 |
| Sep 30, 2023 | 291,191.00 |
| Jun 30, 2023 | 44,215.00 |
| Jun 30, 2023 | 44,215.00 |
| Mar 31, 2023 | 251,134.00 |
| Mar 31, 2023 | 251,134.00 |
| Dec 31, 2022 | 39,235.00 |
| Dec 31, 2022 | 39,235.00 |